Verrica Pharmaceuticals Ownership | Who Owns Verrica Pharmaceuticals?
Verrica Pharmaceuticals Ownership Summary
Verrica Pharmaceuticals is owned by 26.03% institutional investors, 43.45% insiders, and 30.52% retail investors. Caligan partners lp is the largest institutional shareholder, holding 17.36% of VRCA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.37% of its assets in Verrica Pharmaceuticals shares.
VRCA Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Verrica Pharmaceuticals | 26.03% | 43.45% | 30.52% |
Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Caligan partners lp | 8.99M | 17.36% | $3.98M |
Armistice capital | 8.88M | 9.36% | $4.71M |
Vanguard group | 1.88M | 4.02% | $1.32M |
Blackrock | 1.13M | 2.43% | $8.23M |
Geode capital management | 477.27K | 1.02% | $334.13K |
State street | 451.78K | 0.97% | $3.29M |
Millennium management | 395.65K | 0.76% | $174.96K |
Renaissance | 233.30K | 0.50% | $163.31K |
Northern trust | 190.68K | 0.41% | $1.39M |
Ubs group | 174.06K | 0.37% | $121.84K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Caligan partners lp | 8.99M | 0.83% | $3.98M |
Armistice capital | 8.88M | 0.08% | $4.71M |
Bml capital management | 174.65K | 0.07% | $92.58K |
Y-intercept (hong kong) | 186.96K | 0.00% | $99.11K |
Spc financial | 30.00K | 0.00% | $21.00K |
Steel peak wealth management | 76.00K | 0.00% | $40.29K |
Dynamic technology lab private | 20.30K | 0.00% | $11.00K |
Point72 asia (singapore) pte. | 13.72K | 0.00% | $7.27K |
Miracle mile advisors | 84.00K | 0.00% | $58.80K |
Key financial | 9.41K | 0.00% | $4.99K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Caligan partners lp | 8.99M | 0.83% | 1.56M |
Vanguard group | 1.88M | - | 593.31K |
Millennium management | 395.65K | 0.00% | 395.65K |
Armistice capital | 8.88M | 0.08% | 313.94K |
Y-intercept (hong kong) | 186.96K | 0.00% | 186.96K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Avoro capital advisors | - | - | -4.00M |
Perceptive advisors | - | - | -3.25M |
Boothbay fund management | - | - | -2.81M |
Blackrock funding, inc. /de | 56.47K | - | -1.17M |
Fmr | 14.67K | - | -619.64K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Y-intercept (hong kong) | 186.96K | 0.00% | 186.96K | $99.11K |
Dynamic technology lab private | 20.30K | 0.00% | 20.30K | $11.00K |
Aqr capital management | 14.44K | - | 14.44K | $10.11K |
Point72 asia (singapore) pte. | 13.72K | 0.00% | 13.72K | $7.27K |
Raymond james financial | 8.40K | - | 8.40K | $4.45K |
Sold Out
Holder | Change |
---|---|
Nelson, van denburg & campbell wealth management group | -4.00 |
True wealth design | -8.00 |
Sterling capital management | -19.00 |
Mai capital management | -21.00 |
Farther finance advisors | -31.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 52 | -27.78% | 24,696,020 | -16.20% | 26 | 2.70% | 23 | -41.03% | 20 | 100.00% |
Mar 31, 2025 | 3 | -96.25% | 9,407,623 | -68.57% | 18 | 0.44% | 2 | -95.12% | - | -100.00% |
Dec 31, 2024 | 77 | -3.75% | 29,394,921 | 97.36% | 62 | 6.20% | 39 | -9.30% | 18 | 12.50% |
Sep 30, 2024 | 79 | 5.33% | 14,834,226 | -20.43% | 31 | 1.97% | 42 | 7.69% | 16 | - |
Jun 30, 2024 | 74 | 21.31% | 18,643,941 | 5.04% | 40 | 2.62% | 38 | 111.11% | 16 | -20.00% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 127.02K | 1.37% | -2.78K |
Invesco Dorsey Wright SmallCap Momt ETF | 409.00K | 0.96% | - |
Vanguard US Total Market Shares ETF | 815.89K | 0.89% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 65.21K | 0.71% | -15.05K |
Fidelity Select Biotechnology | 517.63K | 0.57% | -112.24K |
iShares Russell 2000 ETF | 520.96K | 0.56% | - |
Simplify Propel Opportunities ETF | 200.00K | 0.44% | - |
Fidelity Small Cap Index | 385.38K | 0.42% | - |
DWS Small Cap Core S | 174.70K | 0.41% | - |
Small Cap Core Equity Composite | 174.70K | 0.41% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Mar 17, 2025 | Hayes Christopher G. | CHIEF LEGAL OFFICER | Sell | $2.80K |
Nov 22, 2024 | Rieger Jayson | CEO and President | Buy | $187.50K |
Nov 22, 2024 | Rieger Jayson | CEO and President | Buy | $150.00K |
Nov 22, 2024 | Rieger Jayson | CEO and President | Buy | $250.00K |
Nov 22, 2024 | Stalfort John A III | - | Buy | $1000.00K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | 1 |
2024 Q4 | 12 | - |
2024 Q3 | - | 18 |
2024 Q2 | - | - |
2024 Q1 | - | - |
VRCA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools